Healthcare - Biotechnology - NASDAQ - US
$ 0.023
0 %
$ 532 K
Market Cap
-0.16
P/E
CASH FLOW STATEMENT
-4.76 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
4.28 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Peak Bio, Inc.
| Net Income | -12.8 M |
| Depreciation & Amortization | 311 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 275 K |
| Change in Working Capital | 3.66 M |
| Others | 5.25 M |
| Free Cash Flow | -4.76 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (12.8) | (13.1) | (8.3) | 2.46 K | 1.27 K |
| Depreciation & Amortization | 0.3 | 0.8 | 0.2 | 39.3 | 8.37 |
| Deferred Income Tax | 0 | (816 037.0) | 0 | 0 | 0 |
| Stock Based Compensation | 0.3 | 0.6 | 4.89 K | 930 | 0 |
| Other Operating Activities | 3.8 | 816 038.9 | (0.8) | 400 | 226 |
| Change in Working Capital | 3.7 | 2.4 | 93.1 K | 149 | 10.6 |
| Cash From Operations | (4.8) | (7.5) | (8.9) | 2.04 K | 1.04 K |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 0 | (0.1) | 9.88 K | 99.5 | 117 |
| Other Items | 0 | 0 | 0 | 1.6 K | 371 |
| Cash From Investing Activities | 0 | (0.1) | 9.88 K | 1.7 K | 488 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 3.4 | 1.6 | 2.0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.7 | 0.1 | 0 | 138 | 12 K |
| Cash From Financing Activities | 4.3 | 8.1 | 8.4 | 138 | 12 K |
| CHANGE IN CASH | |||||
| Net Change In Cash | (0.5) | 0.5 | 32.6 K | 3.37 K | 10.5 K |
| FREE CASH FLOW | |||||
| Free Cash Flow | (4.8) | (7.6) | (8.9) | 2.14 K | 1.16 K |